PubRank

Anna Nadal

Author PubWeight™ 11.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lack of repeatable differential expression patterns between MON810 and comparable commercial varieties of maize. Plant Mol Biol 2008 1.05
2 Natural variation explains most transcriptomic changes among maize plants of MON810 and comparable non-GM varieties subjected to two N-fertilization farming practices. Plant Mol Biol 2010 1.04
3 Gene expression profiles of MON810 and comparable non-GM maize varieties cultured in the field are more similar than are those of conventional lines. Transgenic Res 2009 1.02
4 Effect of volunteers on maize gene flow. Transgenic Res 2009 0.92
5 Only half the transcriptomic differences between resistant genetically modified and conventional rice are associated with the transgene. Plant Biotechnol J 2010 0.92
6 Characterizing the function and structural organization of the 5' tRNA-like motif within the hepatitis C virus quasispecies. Nucleic Acids Res 2005 0.92
7 Proteomic analysis of MON810 and comparable non-GM maize varieties grown in agricultural fields. Transgenic Res 2010 0.88
8 Catalytic RNase P RNA from Synechocystis sp. cleaves the hepatitis C virus RNA near the AUG start codon. FEBS Lett 2004 0.83
9 Medium-term evaluation of an educational intervention on dietary and physical exercise habits in schoolchildren: the Avall 2 study. Endocrinol Nutr 2012 0.82
10 The 7472insC mtDNA mutation impairs 5' and 3' processing of tRNA(Ser(UCN)). Biochem Biophys Res Commun 2004 0.81
11 The production of recombinant cationic α-helical antimicrobial peptides in plant cells induces the formation of protein bodies derived from the endoplasmic reticulum. Plant Biotechnol J 2013 0.81
12 [Weight, dietary patterns and exercise habits in first-year primary school children: the AVall study]. Endocrinol Nutr 2009 0.81
13 Interlaboratory transfer of a real-time polymerase chain reaction assay for quantitative detection of genetically modified maize event TC-1507. J AOAC Int 2006 0.76
14 Three properties of the hepatitis C virus RNA genome related to antiviral strategies based on RNA-therapeutics: variability, structural conformation and tRNA mimicry. Curr Pharm Des 2004 0.75